CAR T cells for solid tumors - developments to watch in 2023

Expert Opin Biol Ther. 2024 Apr;24(4):207-211. doi: 10.1080/14712598.2024.2334399. Epub 2024 Mar 25.

Authors

Marcel P Trefny¹, Sebastian Kobold^{1

2

3}

Affiliations

¹ Division of Clinical Pharmacology, University Hospital, Munich, Germany.
² German Cancer Consortium (DKTK), Partner Site Munich, a partnership between the DKFZ Heidelberg and the University Hospital of the LMU, Germany.
³ Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München - German Research Center for Environmental Health Neuherberg, Germany.

PMID: 38526025
DOI: 10.1080/14712598.2024.2334399

No abstract available

Keywords: CAR T cells; CAR Targets; T cell migration; cellular Immunotherapy; clinical trials; microbiome; solid tumors.

Publication types

Editorial

MeSH terms

Humans
Immunotherapy, Adoptive* / trends
Neoplasms* / immunology
Neoplasms* / therapy
Receptors, Chimeric Antigen* / genetics
Receptors, Chimeric Antigen* / immunology
T-Lymphocytes / immunology
T-Lymphocytes / transplantation

Substances

Receptors, Chimeric Antigen